Allergic Rhinitis Treatment Market, By Treatment Type (Immunotherapy, Anti-histamines, Decongestants, Leukotriene Receptor Antagonists, Corticosteroids, and Others), By Route of Administration, By Distribution Channel, By Geography

Description

The global allergic rhinitis treatment market is estimated to be valued at USD 16.10 Bn in 2024 and is expected to reach USD 22.43 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 4.8% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 16.10 Bn
Historical Data for:	2019 To 2023	Forecast Period:	2024 To 2031
Forecast Period 2024 to 2031 CAGR:	4.80%	2031 Value Projection:	US$ 22.43 Bn

Figure. Allergic Rhinitis Treatment Market Share (%), By Region, 2024

Allergic Rhinitis Treatment Market - IMG1

Allergic rhinitis, commonly known as hay fever, is a condition where the body exhibits an inflammatory response to one or more airborne allergens like pollen or dust. It causes symptoms like sneezing, runny nose, nasal congestion and itchy eyes. The global prevalence of allergic rhinitis has been steadily increasing in recent years due to factors like increasing environmental pollution and changes in lifestyle. According to some estimates, about 10-30% of the global population currently suffers from allergic rhinitis, making it a major health concern. With growing awareness and better diagnosis, the market for drugs to treat allergic rhinitis has also expanded significantly.

Market Dynamics:

The global allergic rhinitis treatment market is driven by the rising prevalence of allergic rhinitis cases globally. The market has also witnessed robust growth due to the increasing environmental pollution levels and changing climate patterns which have led to the proliferation of airborne allergens like pollen. Advancements in diagnosis and treatment options along with higher investments in allergy research by pharmaceutical companies are translating into new product launches and boosting the market growth. However, patent expiries of blockbuster drug brands coupled with the availability of generic alternatives are expected to hamper the growth of innovator drug makers to some extent. Nevertheless, emerging economies like India and China with their huge population base suffering from allergies present lucrative opportunities for market players in the coming years.

Key Features of the Study:

This report provides an in-depth analysis of the global allergic rhinitis treatment market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global allergic rhinitis treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this includes Merck & Co., Inc., Boehringer Ingelheim International GmbH, AstraZeneca, GSK plc., Johnson & Johnson Services, Inc., Teva Pharmaceutical Industries Ltd., Novartis AG, Mylan N.V., Aytu BioPharma, Inc., Regeneron Pharmaceuticals Inc., Revolo Biotherapeutics, Dr. Reddy's Laboratories Ltd, Glenmark Pharmaceuticals Ltd, Bayer AG, Alembic Pharmaceuticals Limited, Sanofi, Hikma Pharmaceuticals PLC.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global allergic rhinitis treatment market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global allergic rhinitis treatment market.

Detailed Segmentation-

By Treatment Type:
- Immunotherapy
- Sub-cutaneous Immunotherapy (SCIT)
- Sub-lingual Immunotherapy (SLIT)
- Anti-histamines
- Decongestants
- Leukotriene Receptor Antagonists
- Corticosteroids
- Others
By Route of Administration:
- Oral
- Nasal
- Intraocular
- Others
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- E-commerce
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Merck & Co., Inc.
- Boehringer Ingelheim International GmbH
- AstraZeneca
- GSK plc.
- Johnson & Johnson Services, Inc.
- Teva Pharmaceutical Industries Ltd.
- Novartis AG
- Mylan N.V.
- Aytu BioPharma, Inc.
- Regeneron Pharmaceuticals Inc.
- Revolo Biotherapeutics
- Reddy's Laboratories Ltd
- Glenmark Pharmaceuticals Ltd
- Bayer AG
- Alembic Pharmaceuticals Limited
- Sanofi
- Hikma Pharmaceuticals PLC

Product Code: CMI1201

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Treatment Type
- Market Snapshot, By Route of Administration
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Pipeline Analysis
Epidemiology
Acquisitions and Partnerships Scenario
Product Launches/Approvals
Brand and Pricing Analysis
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Allergic Rhinitis Treatment Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Allergic Rhinitis Treatment Market, By Treatment Type, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Immunotherapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Sub-cutaneous Immunotherapy (SCIT)
Sub-lingual Immunotherapy (SLIT)
Anti-histamines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Decongestants
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Leukotriene Receptor Antagonists
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Corticosteroids
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Allergic Rhinitis Treatment Market, By Route of Administration, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Oral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Nasal
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Intraocular
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Allergic Rhinitis Treatment Market, By Distribution Channel, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
E-commerce
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Allergic Rhinitis Treatment Market, By Region, 2019 - 2031, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2019-2031
- Regional Trends
  - North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.S.
  - Canada
  - Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
  - Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
  - Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
  - Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
  - Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profiles
- Merck & Co., Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Boehringer Ingelheim International GmbH
- AstraZeneca
- GSK plc.
- Johnson & Johnson Services, Inc.
- Teva Pharmaceutical Industries Ltd.
- Novartis AG
- Mylan N.V.
- Aytu BioPharma, Inc.
- Regeneron Pharmaceuticals Inc.
- Revolo Biotherapeutics
- Dr. Reddy's Laboratories Ltd
- Glenmark Pharmaceuticals Ltd
- Bayer AG
- Alembic Pharmaceuticals Limited
- Sanofi
- Hikma Pharmaceuticals PLC

10. Analyst View

Wheel of Fortune
Analyst View
Coherent Opportunity Map

11. References and Research Methodology

References
Research Methodology
About us and Sales Contact